ZELDIS JEROME B
Insider CIK 1433982 · ALQA.OB Director · PTCT Director · MTST.OB Director · NONE Director · BSGM Director · NEXI Executive VP of Research & Dev · SNGX Director · SRNE See Remarks
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SNGX SOLIGENIX, INC. | D To issuer deriv | 2026-10-12 | 2026-10-13 | 192 | — | $0 | 0 | SEC↗ |
| SNGX SOLIGENIX, INC. | D To issuer deriv | 2026-10-12 | 2026-10-13 | 121 | — | $0 | 0 | SEC↗ |
| SNGX SOLIGENIX, INC. | D To issuer deriv | 2026-10-12 | 2026-10-13 | 63 | — | $0 | 0 | SEC↗ |
| SNGX SOLIGENIX, INC. | D To issuer deriv | 2026-10-12 | 2026-10-13 | 128 | — | $0 | 0 | SEC↗ |
| SNGX SOLIGENIX, INC. | D To issuer deriv | 2026-10-12 | 2026-10-13 | 74 | — | $0 | 0 | SEC↗ |
| SNGX SOLIGENIX, INC. | D To issuer deriv | 2026-10-12 | 2026-10-13 | 54 | — | $0 | 0 | SEC↗ |
| SNGX SOLIGENIX, INC. | A Award deriv | 2026-09-17 | 2026-09-18 | 78,947 | — | $0 | 78,947 | SEC↗ |
| SNGX SOLIGENIX, INC. | A Award deriv | 2026-09-17 | 2026-09-18 | 78,947 | — | $0 | 78,947 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | A Award deriv | 2026-01-02 | 2026-01-06 | 3,475 | — | $0 | 3,475 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | A Award | 2026-01-02 | 2026-01-06 | 4,000 | — | $0 | 22,500 | SEC↗ |
| NXGL NEXGEL, INC. | A Award deriv | 2025-06-25 | 2025-06-27 | 30,000 | — | $0 | 30,000 | SEC↗ |
| SNGX SOLIGENIX, INC. | A Award deriv | 2025-06-20 | 2025-06-20 | 17,647 | — | $0 | 17,647 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | A Award deriv | 2025-01-03 | 2025-01-07 | 8,800 | — | $0 | 8,800 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | A Award | 2025-01-03 | 2025-01-07 | 4,000 | — | $0 | 18,500 | SEC↗ |
| SNGX SOLIGENIX, INC. | A Award deriv | 2024-12-12 | 2024-12-13 | 8,646 | — | $0 | 8,646 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | M Exercise deriv | 2024-12-02 | 2024-12-04 | 12,000 | — | $0 | 0 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | M Exercise deriv | 2024-12-02 | 2024-12-04 | 12,000 | — | $0 | 0 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | M Exercise | 2024-12-02 | 2024-12-04 | 12,000 | $51.00 | $612.0K | 26,500 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | S Sale | 2024-12-02 | 2024-12-04 | 3,187 | $52.42 | $167.1K | 14,500 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | S Sale | 2024-12-02 | 2024-12-04 | 8,813 | $51.44 | $453.3K | 17,687 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | S Sale | 2024-12-02 | 2024-12-04 | 5,699 | $50.52 | $287.9K | 20,801 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | S Sale | 2024-12-02 | 2024-12-04 | 2,634 | $51.43 | $135.5K | 18,167 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | S Sale | 2024-12-02 | 2024-12-04 | 3,667 | $52.39 | $192.1K | 14,500 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | M Exercise | 2024-12-02 | 2024-12-04 | 12,000 | $30.86 | $370.3K | 26,500 | SEC↗ |
| NXGL NEXGEL, INC. | A Award deriv | 2024-11-20 | 2024-11-22 | 1,818 | — | $0 | 1,818 | SEC↗ |
| NXGL NEXGEL, INC. | P Buy | 2024-11-20 | 2024-11-22 | 3,636 | $2.75 | $10.0K | 106,664 | SEC↗ |
| NXGL NEXGEL, INC. | A Award deriv | 2024-09-13 | 2024-09-17 | 25,000 | — | $0 | 25,000 | SEC↗ |
| NXGL NEXGEL, INC. | A Award deriv | 2024-08-23 | 2024-08-27 | 5,000 | — | $0 | 5,000 | SEC↗ |
| NXGL NEXGEL, INC. | P Buy | 2024-08-23 | 2024-08-27 | 10,000 | $2.50 | $25.0K | 103,028 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | M Exercise deriv | 2024-05-22 | 2024-05-24 | 20,000 | — | $0 | 0 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | M Exercise | 2024-05-22 | 2024-05-24 | 20,000 | $26.42 | $528.4K | 34,500 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | S Sale | 2024-05-22 | 2024-05-24 | 20,000 | $38.24 | $764.8K | 14,500 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | A Award deriv | 2024-02-15 | 2024-02-16 | 10,000 | — | $0 | 10,000 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | A Award | 2024-02-15 | 2024-02-16 | 4,000 | — | $0 | 14,500 | SEC↗ |
| SNGX SOLIGENIX, INC. | A Award deriv | 2023-12-15 | 2023-12-15 | 38,136 | — | $0 | 38,136 | SEC↗ |
| NXGL NEXGEL, INC. | A Award deriv | 2023-08-17 | 2023-08-21 | 15,000 | — | $0 | 15,000 | SEC↗ |
| NXGL NEXGEL, INC. | P Buy | 2023-05-26 | 2023-05-30 | 5,000 | $2.34 | $11.7K | 93,028 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | A Award deriv | 2023-01-05 | 2023-01-09 | 10,000 | — | $0 | 10,000 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | A Award | 2023-01-05 | 2023-01-09 | 4,000 | — | $0 | 10,500 | SEC↗ |
| SNGX SOLIGENIX, INC. | A Award deriv | 2022-11-17 | 2022-11-21 | 46,154 | — | $0 | 145,285 | SEC↗ |
| NEXI NexImmune, Inc. | A Award deriv | 2022-04-05 | 2022-04-07 | 80,100 | — | $0 | 80,100 | SEC↗ |
| NXGL NEXGEL, INC. | P Buy | 2022-03-25 | 2022-03-28 | 5,300 | $1.89 | $10.0K | 88,028 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | A Award deriv | 2022-01-07 | 2022-01-11 | 12,000 | — | $0 | 12,000 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | A Award | 2022-01-07 | 2022-01-11 | 3,200 | — | $0 | 6,500 | SEC↗ |
| NXGL NEXGEL, INC. | A Award deriv | 2021-12-27 | 2022-01-03 | 9,091 | $0.01 | $91 | 9,091 | SEC↗ |
| NXGL NEXGEL, INC. | P Buy | 2021-12-27 | 2022-01-03 | 9,091 | $5.49 | $49.9K | 82,728 | SEC↗ |
| SNGX SOLIGENIX, INC. | A Award deriv | 2021-09-23 | 2021-09-24 | 29,126 | — | $0 | 29,126 | SEC↗ |
| SNGX SOLIGENIX, INC. | S Sale | 2021-05-14 | 2021-05-18 | 3,000 | $0.90 | $2.7K | 22,917 | SEC↗ |
| SNGX SOLIGENIX, INC. | P Buy | 2021-05-14 | 2021-05-18 | 3,000 | $0.89 | $2.7K | 25,917 | SEC↗ |
| NONE NEXGEL, INC. | A Award deriv | 2021-03-08 | 2021-03-12 | 666,667 | — | $0 | 666,667 | SEC↗ |
| NEXI NexImmune, Inc. | P Buy | 2021-02-17 | 2021-02-19 | 5,882 | $17.00 | $100.0K | 5,882 | SEC↗ |
| NEXI NexImmune, Inc. | A Award deriv | 2021-02-11 | 2021-02-16 | 351,016 | — | $0 | 351,016 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | A Award deriv | 2021-01-06 | 2021-01-08 | 10,000 | — | $0 | 10,000 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | A Award | 2021-01-06 | 2021-01-08 | 1,650 | — | $0 | 3,300 | SEC↗ |
| SNGX SOLIGENIX, INC. | A Award deriv | 2020-09-16 | 2020-09-18 | 15,228 | — | $0 | 15,228 | SEC↗ |
| BSGM BioSig Technologies, Inc. | A Award deriv | 2020-07-14 | 2020-07-15 | 50,000 | — | $0 | 50,000 | SEC↗ |
| BSGM BioSig Technologies, Inc. | P Buy | 2020-05-28 | 2020-05-28 | 1,000 | $10.49 | $10.5K | 107,944 | SEC↗ |
| BSGM BioSig Technologies, Inc. | A Award deriv | 2020-04-14 | 2020-04-16 | 50,000 | — | $0 | 50,000 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | A Award deriv | 2020-01-29 | 2020-01-31 | 10,000 | — | $0 | 10,000 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | A Award | 2020-01-29 | 2020-01-31 | 1,650 | — | $0 | 1,650 | SEC↗ |
| SNGX SOLIGENIX, INC. | P Buy | 2019-11-19 | 2019-11-19 | 2,000 | $0.93 | $1.9K | 22,917 | SEC↗ |
| BSGM BioSig Technologies, Inc. | A Award deriv | 2019-10-30 | 2019-10-31 | 29,000 | — | $0 | 29,000 | SEC↗ |
| SNGX SOLIGENIX, INC. | P Buy | 2019-09-19 | 2019-09-23 | 4,000 | $0.94 | $3.8K | 20,917 | SEC↗ |
| SNGX SOLIGENIX, INC. | A Award deriv | 2019-09-06 | 2019-09-10 | 30,928 | — | $0 | 30,928 | SEC↗ |
| BSGM BioSig Technologies, Inc. | M Exercise deriv | 2019-05-22 | 2019-05-22 | 20,000 | — | $0 | 0 | SEC↗ |
| BSGM BioSig Technologies, Inc. | M Exercise deriv | 2019-05-22 | 2019-05-22 | 1,097 | — | $0 | 0 | SEC↗ |
| BSGM BioSig Technologies, Inc. | M Exercise | 2019-05-22 | 2019-05-22 | 1,097 | $6.85 | $7.5K | 106,944 | SEC↗ |
| BSGM BioSig Technologies, Inc. | M Exercise | 2019-05-22 | 2019-05-22 | 20,000 | $3.40 | $68.0K | 105,847 | SEC↗ |
| BSGM BioSig Technologies, Inc. | C Conversion deriv | 2019-05-21 | 2019-05-22 | 50 | — | $0 | 0 | SEC↗ |
| BSGM BioSig Technologies, Inc. | A Award | 2019-05-21 | 2019-05-22 | 3,804 | $7.44 | $28.3K | 85,847 | SEC↗ |
| BSGM BioSig Technologies, Inc. | C Conversion | 2019-05-21 | 2019-05-22 | 13,334 | $3.75 | $50.0K | 82,043 | SEC↗ |
| SNGX SOLIGENIX, INC. | P Buy | 2019-04-22 | 2019-04-22 | 10,000 | $0.73 | $7.3K | 16,917 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | A Award deriv | 2019-01-22 | 2019-01-24 | 14,000 | — | $0 | 14,000 | SEC↗ |
| SRNE Sorrento Therapeutics, Inc | A Award deriv | 2018-11-26 | 2018-11-27 | 100,000 | — | $0 | 100,000 | SEC↗ |
| SNGX SOLIGENIX, INC. | A Award deriv | 2018-09-27 | 2018-09-28 | 17,964 | — | $0 | 17,964 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | A Award deriv | 2018-01-03 | 2018-01-05 | 14,000 | — | $0 | 14,000 | SEC↗ |
| MTST MetaStat, Inc. | M Exercise deriv | 2017-10-11 | 2017-11-21 | 50,000 | — | $0 | 50,000 | SEC↗ |
| SRNE Sorrento Therapeutics, Inc | A Award deriv | 2017-09-14 | 2017-09-15 | 150,000 | — | $0 | 150,000 | SEC↗ |
| ALQA Alliqua BioMedical, Inc. | A Award deriv | 2017-06-30 | 2017-07-03 | 90,000 | — | $0 | 90,000 | SEC↗ |
| ALQA Alliqua BioMedical, Inc. | J Other | 2017-06-23 | 2017-06-26 | 100,000 | — | $0 | 786,750 | SEC↗ |
| SNGX SOLIGENIX, INC. | A Award deriv | 2017-06-08 | 2017-06-12 | 13,100 | — | $0 | 13,100 | SEC↗ |
| MTST.OB MetaStat, Inc. | P Buy | 2017-04-04 | 2017-04-06 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ALQA Alliqua BioMedical, Inc. | P Buy | 2017-02-27 | 2017-03-01 | 400,000 | $0.50 | $200.0K | 686,750 | SEC↗ |
| SRNE Sorrento Therapeutics, Inc | P Buy | 2017-02-03 | 2017-02-03 | 10,000 | $5.15 | $51.5K | 10,000 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | A Award deriv | 2017-01-03 | 2017-01-05 | 12,000 | — | $0 | 12,000 | SEC↗ |
| BSGM BioSig Technologies, Inc. | A Award deriv | 2016-12-22 | 2017-02-09 | 50,000 | — | $0 | 50,000 | SEC↗ |
| SRNE Sorrento Therapeutics, Inc | A Award deriv | 2016-08-12 | 2016-11-15 | 200,000 | — | $0 | 200,000 | SEC↗ |
| SNGX SOLIGENIX, INC. | A Award deriv | 2016-06-16 | 2016-06-20 | 40,541 | — | $0 | 40,541 | SEC↗ |
| ALQA Alliqua BioMedical, Inc. | A Award deriv | 2016-05-11 | 2016-05-13 | 45,000 | — | $0 | 45,000 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | A Award deriv | 2016-01-04 | 2016-01-06 | 12,000 | — | $0 | 12,000 | SEC↗ |
| SNGX SOLIGENIX, INC. | P Buy | 2015-12-23 | 2015-12-23 | 2,500 | $1.27 | $3.2K | 69,166 | SEC↗ |
| ALQA Alliqua BioMedical, Inc. | P Buy | 2015-11-06 | 2015-11-09 | 14,000 | $2.91 | $40.7K | 286,750 | SEC↗ |
| SNGX SOLIGENIX, INC. | A Award deriv | 2015-06-18 | 2015-06-19 | 19,868 | — | $0 | 19,868 | SEC↗ |
| ALQA Alliqua BioMedical, Inc. | A Award deriv | 2015-05-06 | 2015-05-08 | 15,000 | — | $0 | 15,000 | SEC↗ |
| SNGX SOLIGENIX, INC. | M Exercise deriv | 2015-04-09 | 2015-04-09 | 17,857 | — | $0 | 0 | SEC↗ |
| SNGX SOLIGENIX, INC. | M Exercise | 2015-04-09 | 2015-04-09 | 17,857 | $0.61 | $10.9K | 66,666 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | A Award deriv | 2015-01-02 | 2015-01-02 | 12,000 | $51.00 | $612.0K | 12,000 | SEC↗ |
| ALQA Alliqua BioMedical, Inc. | M Exercise deriv | 2014-09-03 | 2014-09-04 | 23,500 | — | $0 | 174,031 | SEC↗ |
| ALQA Alliqua BioMedical, Inc. | M Exercise | 2014-09-03 | 2014-09-04 | 23,500 | $4.24 | $99.6K | 272,750 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | A Award deriv | 2014-07-31 | 2014-08-01 | 20,000 | $26.42 | $528.4K | 20,000 | SEC↗ |
| SNGX SOLIGENIX, INC. | A Award deriv | 2014-06-19 | 2014-06-20 | 13,669 | — | $0 | 13,669 | SEC↗ |
| ALQA Alliqua, Inc. | M Exercise deriv | 2014-06-06 | 2014-06-10 | 23,500 | — | $0 | 4,719 | SEC↗ |
| ALQA Alliqua, Inc. | M Exercise | 2014-06-06 | 2014-06-10 | 23,500 | $4.24 | $99.6K | 249,250 | SEC↗ |
| ALQA Alliqua, Inc. | A Award deriv | 2014-03-06 | 2014-03-10 | 5,000 | — | $0 | 5,000 | SEC↗ |
| ALQA Alliqua, Inc. | A Award deriv | 2013-11-14 | 2013-12-16 | 57,143 | — | $0 | 57,143 | SEC↗ |
| SNGX SOLIGENIX, INC. | A Award deriv | 2013-09-27 | 2013-10-01 | 13,275 | — | $0 | 13,275 | SEC↗ |
| ALQA Alliqua, Inc. | D To issuer deriv | 2013-07-22 | 2013-07-25 | 5,000,000 | — | $0 | 0 | SEC↗ |
| ALQA Alliqua, Inc. | D To issuer deriv | 2013-07-22 | 2013-07-25 | 4,640,000 | — | $0 | 0 | SEC↗ |
| ALQA Alliqua, Inc. | A Award deriv | 2013-07-22 | 2013-07-25 | 9,073,334 | — | $0 | 9,073,334 | SEC↗ |
| ALQA Alliqua, Inc. | A Award deriv | 2013-07-22 | 2013-07-25 | 9,073,333 | — | $0 | 9,073,333 | SEC↗ |
| ALQA Alliqua, Inc. | A Award deriv | 2013-07-22 | 2013-07-25 | 9,073,333 | — | $0 | 9,073,333 | SEC↗ |
| ALQA Alliqua, Inc. | D To issuer deriv | 2013-07-22 | 2013-07-25 | 2,500,000 | — | $0 | 0 | SEC↗ |
| ALQA Alliqua, Inc. | A Award deriv | 2013-06-28 | 2013-07-02 | 8,641,975 | — | $0 | 8,641,975 | SEC↗ |
| ALQA Alliqua, Inc. | P Buy | 2013-06-28 | 2013-07-02 | 8,641,975 | — | $0 | 9,876,543 | SEC↗ |
| SNGX SOLIGENIX, INC. | P Buy deriv | 2013-06-25 | 2013-06-26 | 17,857 | — | $0 | 17,857 | SEC↗ |
| SNGX SOLIGENIX, INC. | P Buy | 2013-06-25 | 2013-06-26 | 23,809 | $1.05 | $25.0K | 48,809 | SEC↗ |
| SNGX SOLIGENIX, INC. | M Exercise deriv | 2013-06-20 | 2013-06-24 | 25,000 | — | $0 | 0 | SEC↗ |
| SNGX SOLIGENIX, INC. | M Exercise | 2013-06-20 | 2013-06-24 | 25,000 | $0.30 | $7.5K | 25,000 | SEC↗ |
| ALQA Alliqua, Inc. | A Award deriv | 2013-02-22 | 2013-02-25 | 1,234,568 | — | $0 | 1,234,568 | SEC↗ |
| ALQA Alliqua, Inc. | P Buy | 2013-02-22 | 2013-02-25 | 1,234,568 | — | $0 | 1,234,568 | SEC↗ |
| ALQA Alliqua, Inc. | A Award deriv | 2012-11-27 | 2013-02-26 | 150,000 | — | $0 | 150,000 | SEC↗ |
| ALQA.OB Alliqua, Inc. | A Award deriv | 2012-11-27 | 2012-11-29 | 20,000,000 | — | $0 | 20,000,000 | SEC↗ |
| SNGX SOLIGENIX, INC. | A Award deriv | 2012-06-21 | 2012-07-25 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ALQA.OB Alliqua, Inc. | A Award deriv | 2012-05-17 | 2012-05-21 | 8,120,000 | — | $0 | 8,120,000 | SEC↗ |
| ALQA.OB Alliqua, Inc. | A Award deriv | 2012-05-17 | 2012-05-21 | 15,080,000 | — | $0 | 23,200,000 | SEC↗ |